Skip to main navigation
Skip to search
Skip to main content
UNIC | Research Portal Home
Home
Profiles
Research units
Research output
Projects
Search by expertise, name or affiliation
Permitted daily exposure of the androgen receptor antagonist flutamide
Lefteris C. Zacharia
School of Life and Health Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Permitted daily exposure of the androgen receptor antagonist flutamide'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Permitted Daily Exposure
100%
Androgen Receptor Antagonist
100%
Flutamide
100%
No Adverse Effect
37%
Effect Level
37%
Toxicity Study
25%
28-day Toxicity Study
25%
Dose Effect
12%
Route of Administration
12%
Androgen Receptor
12%
Non-monotonic Dose Response
12%
Risk to Humans
12%
NOAEL
12%
Oral Route
12%
Developmental Toxicity Studies
12%
Receptor Blockers
12%
Pharmacology, Toxicology and Pharmaceutical Science
Flutamide
100%
Androgen Receptor Antagonist
100%
Adverse Event
60%
Route of Administration
20%
Developmental Toxicity
20%
Lowest-Observed-Adverse-Effect Level
20%